ucsf logobch logo

Aris H. Oates, MD

Nephrology • Pediatric Nephrology
Portrait of Aris H. Oates
Portrait of Aris H. Oates
ucsf logobch logo

Aris H. Oates, MD

Nephrology • Pediatric Nephrology

On this page

About me

Dr. Aris Oates is a nephrologist who cares for children with conditions that affect renal (kidney) function, such as acute kidney injury and nephrotic syndrome (disorder characterized by the excretion of too much protein in the urine). He also treats complex renal disorders and conditions that affect the urinary tract, such a kidney stones and hydronephrosis (build up of urine causing kidney swelling). He manages blood pressure and also treats children with fluid and electrolyte disorders.

In research, Oates focuses on improving patient health through information technology. Specifically, he brings together initiatives on quality improvement and patient safety to advance electronic health records, communication systems and health system data.

Oates earned his medical degree at Rush Medical College. He completed a residency in pediatrics and a fellowship in pediatric nephrology at UCSF.

Education & training

Board certification

  • Clinical Informatics, American Board of Preventive Medicine
  • Pediatric Nephrology, American Board of Pediatrics
  • Pediatrics, American Board of Pediatrics

Fellowship

  • Pediatric Nephrology, UCSF Medical Center House Staff

Residency

  • Pediatrics, UCSF Medical Center House Staff

Degree

  • MD, Rush Medical College

My expertise

  • Specialties
    • Nephrology
    • Pediatric Nephrology
  • Conditions
    • Hydronephrosis
    • Kidney Stone
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.